Price Band
₹1008 - ₹1062
Lot Size
14
Issue Size
₹655.37 Cr
GMP
N/A
Subscription
144.54x
Analyzing...
IPO Schedule
1
Open
8 Dec 2025
2
Close
10 Dec 2025
3
Allotment
-
4
Listing
15 Dec 2025
About Corona Remedies
Corona Remedies is a pharmaceutical company focused on manufacturing, marketing, and distributing a diverse range of pharmaceutical products across various therapeutic areas. Their portfolio includes formulations catering to diverse medical needs with a significant presence in the Indian pharmaceutical market.
Key Strengths
- Diversified product portfolio across multiple therapeutic areas, reducing dependence on a single segment.
- Established distribution network and strong relationships with healthcare professionals.
- Consistent financial performance with robust revenue growth and profitability.
- Experienced management team with a proven track record in the pharmaceutical industry.
- Focus on innovation and new product development to expand market reach.
Risk Factors
- •Dependence on regulatory approvals and compliance with stringent quality standards.
- •Exposure to intense competition from established pharmaceutical companies.
- •Potential impact of pricing pressures and government regulations on profitability.
Valuation Analysis
The IPO is priced at a P/E of 43.47, which appears relatively high compared to some peers. Investors should carefully consider the company's growth prospects and industry dynamics before investing.
IPO Details
ExchangeNSE
SegmentMAINBOARD
ISININE02ZQ01018
NSE SymbolCORONA
Face Value₹10
Lot Size14
Issue Size₹655.37 Cr
Key Metrics
ROE27.50%
ROCE41.32%
P/E Ratio43.47
Industry P/E20
EPS24.43
PAT Margin12.49%
Debt/Equity0.10
Growth & Quality
ProfitableYes ✓
Subscription
Total0.67x
Imbalance Ratio8.9x
Documents
RHP not available
Key Dates
Open Date8 Dec 2025
Close Date10 Dec 2025
Listing15 Dec 2025